Co-founder and Computational Lead
Andrew Ferguson is responsible for leading the computational, machine learning, and software development efforts at Evozyne. Andrew is an Associate Professor at the Pritzker School of Molecular Engineering at the University of Chicago. His research uses theory, simulation, and machine learning to understand and design self-assembling materials, macromolecular folding, and antiviral therapies. He holds a Ph.D. in chemical and biological engineering from Princeton University, and was a Postdoctoral Fellow of the Ragon Institute of MGH, MIT, and Harvard.